Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gartner Inc (IT) vs Novavax Inc (NVAX) Price & Performance

Gartner IncTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

Gartner Inc vs Novavax Inc — how do they compare? Gartner Inc trades at $187.27 (market cap $12.20B), while Novavax Inc trades at $7.96 (market cap $1.30B). The key difference: Gartner Inc is far larger — about 9.4× Novavax Inc's market cap. Which is the better fit depends on your goals.

ITNVAX
Market Cap
$12.20B$1.30B
Sector
TechnologyHealth
52-Week High
$264.09$11.19
52-Week Low
$125.68$6.22
Enterprise Value
$13.94B$879.40M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gartner Inc

Gartner (IT) trades at $185.6, up 0.42% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust profitability with a 69.63% gross margin and 12% net income margin, though revenue growth has moderated. Recent news highlights Q2 2026 earnings exceeding expectations and raised full-year EPS guidance, driving positive investor sentiment.

Outlook is supported by valuation discounts (P/E 16.69) and high ROE (113.58%), but risks include consulting segment weakness and negative net cash flow trends. Analysts are mixed with a $172.80 consensus target, suggesting cautious optimism amid execution challenges.

Novavax Inc

Novavax (NVAX) trades at $7.95, up 2.71% with a bullish technical signal despite negative profitability metrics. The company shows mixed fundamentals with strong revenue growth to $1.12B in 2025 but negative net income margins. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 revenue outlook while cutting expenses. Analyst sentiment remains positive with 74% buy ratings.

Investment outlook balances strong partnerships and pipeline potential against persistent cash burn and negative equity. The Sanofi collaboration and Matrix-M adjuvant platform offer growth catalysts, but operational losses and high debt levels present significant risks. Stock appears undervalued on some metrics but requires careful monitoring of cash flow sustainability.

Returns comparison

Trailing returns across standard periods

About Gartner Inc

Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.

Read more on IT

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX